
|Articles|October 1, 2012
Typical cutaneous malignancies can do not-so-typical things
A patient's immunodeficiency and/or sheer neglect of basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) tumors can result in very large, difficult-to-resect lesions, begging the need for higher vigilance and closer patient care, said Robert E. Clark, M.D., Ph.D., of the Cary Skin Center, Cary, N.C., at the 2012 meeting of Mastering Advances in Dermatology: Beyond Skin Deep in April.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population
2
Medicus Pharma Completes Phase 2 Enrollment of D-MNA Study to Non-Invasively Treat BCC
3
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
4
Phase 2 Nemolizumab Trial Opens for CPUO
5


















